Product Information
CARBIDOPA-LEVO 25-100 MG ODT is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.7166 per EA under NDC 16571015801. Its NADAC has been published 22 times since Jan 28, 2026.
The High Outlier badge above means this manufacturer's average price in the carbidopa and levodopa market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25; 100 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571015801
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA078893On Market Since
1/8/2025
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVO 25-100 MG ODT has been published 22 times since Jan 28, 2026, and over the history we have for it it has declined 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7166 per EA |
|---|---|
| All-time high | $0.7612 (Feb 11, 2026) |
| All-time low | $0.7166 (Jun 17, 2026) |
| 52-week high | $0.7612 |
| 52-week low | $0.7166 |
| Median price | $0.7495 |
| Average price | $0.7454 |
| Largest weekly change | -2.2% (Apr 22, 2026) |
| Weeks tracked | 22 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVO 25-100 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO 25-100 MG ODT, manufactured by Rising Pharma Holdings Inc., is $0.7166 per EA (NDC 16571015801), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVO 25-100 MG ODT changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVO 25-100 MG ODT has declined 5.9%. It has been tracked across 22 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO 25-100 MG ODT?
Since Jan 28, 2026, the NADAC for CARBIDOPA-LEVO 25-100 MG ODT has ranged from a low of $0.7166 (Jun 17, 2026) to a high of $0.7612 (Feb 11, 2026), with a median of $0.7495 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVO 25-100 MG ODT?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CARBIDOPA-LEVODOPA 25-100 TAB, is $0.0724 per EA — about 90% below CARBIDOPA-LEVO 25-100 MG ODT.
Who manufactures CARBIDOPA-LEVO 25-100 MG ODT?
CARBIDOPA-LEVO 25-100 MG ODT (NDC 16571015801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification